Ishibashi S, Sakakura K, Jinnouchi H, Taniguchi Y, Tsukui T, Watanabe Y
Cardiovasc Interv Ther. 2025; .
PMID: 39987417
DOI: 10.1007/s12928-025-01109-6.
Jinnouchi H, Sakakura K, Fujita H
Cardiovasc Interv Ther. 2025; 40(2):234-244.
PMID: 39899261
DOI: 10.1007/s12928-025-01096-8.
Saito Y, Tateishi K, Kobayashi Y
Circ Rep. 2025; 7(1):6-14.
PMID: 39802125
PMC: 11711789.
DOI: 10.1253/circrep.CR-24-0141.
Drost S, Drost C
Cardiovasc Eng Technol. 2025; .
PMID: 39753923
DOI: 10.1007/s13239-024-00765-8.
Ogawa T, Sakakura K, Sumitsuji S, Hyodo M, Yamaguchi J, Hirase H
Cardiovasc Interv Ther. 2024; 40(1):1-32.
PMID: 39627466
PMC: 11723903.
DOI: 10.1007/s12928-024-01044-y.
Recommendations for prediction models in clinical practice guidelines for cardiovascular diseases are over-optimistic: a global survey utilizing a systematic literature search.
Jing C, Zhang L, Feng L, Li J, Liang L, Hu J
Front Cardiovasc Med. 2024; 11:1449058.
PMID: 39484015
PMC: 11524858.
DOI: 10.3389/fcvm.2024.1449058.
Relationship between the number of drugs used during percutaneous coronary intervention and adverse events in patients with chronic coronary syndrome: Analysis of CLIDAS database.
Hitomi Y, Imai Y, Kuwabara M, Oba Y, Kabutoya T, Kario K
Int J Cardiol Heart Vasc. 2024; 54:101507.
PMID: 39314922
PMC: 11417200.
DOI: 10.1016/j.ijcha.2024.101507.
The left axillary artery is a reasonable option as the inflow site for saphenous vein graft in minimally invasive coronary artery bypass grafting.
Ushioda R, Hirofuji A, Yoongtong D, Sakboon B, Cheewinmethasiri J, Lokeskrawee T
Front Cardiovasc Med. 2024; 11:1397396.
PMID: 39234611
PMC: 11371611.
DOI: 10.3389/fcvm.2024.1397396.
Has the surgeon's nightmare of graft spasm been solved?.
Sugiyama K, Matsuyama K
J Thorac Dis. 2024; 16(7):4832-4835.
PMID: 39144318
PMC: 11320269.
DOI: 10.21037/jtd-24-185.
Bail-Out Techniques in Percutaneous Intervention for Ellis Grade III Coronary Perforation in Left Main Distal Bifurcation Lesions.
Takagi K, Yoshida R, Fujita T, Noguchi T
J Soc Cardiovasc Angiogr Interv. 2024; 2(3):100609.
PMID: 39130718
PMC: 11307895.
DOI: 10.1016/j.jscai.2023.100609.
State-of-the-art percutaneous coronary intervention for left main coronary artery disease in Japan.
Warisawa T, Sonoda S, Yamaji K, Amano T, Kohsaka S, Natsuaki M
Cardiovasc Interv Ther. 2024; 39(4):386-402.
PMID: 39078544
DOI: 10.1007/s12928-024-01030-4.
Low-Attenuation Coronary Plaque Volume and Cardiovascular Events in Patients with Distinct Metabolic Phenotypes with or without Diabetes.
Otsuka K, Ishikawa H, Shimada K, Hojo K, Yamaura H, Kono Y
Rev Cardiovasc Med. 2024; 24(12):361.
PMID: 39077073
PMC: 11272880.
DOI: 10.31083/j.rcm2412361.
Benchmarking System Monitoring on Quality Improvement in Percutaneous Coronary Intervention: A Nationwide Registry in Japan.
Saito Y, Inohara T, Kohsaka S, Wada H, Kumamaru H, Yamaji K
JACC Asia. 2024; 4(4):323-331.
PMID: 38660107
PMC: 11035937.
DOI: 10.1016/j.jacasi.2023.12.003.
Conflicts of Interest Among Cardiology Clinical Practice Guideline Authors in Japan.
Murayama A, Aizawa M, Byreddy K, Higuchi K, Senoo Y
J Am Heart Assoc. 2024; 13(8):e034506.
PMID: 38606773
PMC: 11262514.
DOI: 10.1161/JAHA.124.034506.
Cardiac Optical Coherence Tomography: History, Current Status, and Perspective.
Yonetsu T, Jang I
JACC Asia. 2024; 4(2):89-107.
PMID: 38371282
PMC: 10866736.
DOI: 10.1016/j.jacasi.2023.10.001.
Rapid three-dimensional quantification of high-intensity plaques from coronary atherosclerosis T-weighted characterization to predict periprocedural myocardial injury.
Nakazawa M, Matsumoto H, Li D, Slomka P, Dey D, Cadet S
J Cardiovasc Magn Reson. 2024; 26(1):100999.
PMID: 38237903
PMC: 11211226.
DOI: 10.1016/j.jocmr.2024.100999.
Comparison of Discriminative Ability of Bleeding Risk Criteria and Scores for Predicting Short- and Mid-Term Major Bleeding Events in Patients Undergoing Percutaneous Coronary Intervention.
Shimono H, Tokushige A, Kanda D, Ohno A, Arikawa R, Chaen H
Circ Rep. 2024; 6(1):4-15.
PMID: 38196402
PMC: 10774022.
DOI: 10.1253/circrep.CR-23-0087.
Thoracic Aortic Plaque Burden and Prediction of Cardiovascular Events in Patients Undergoing 320-row Multidetector CT Coronary Angiography.
Otsuka K, Ishikawa H, Yamaura H, Hojo K, Kono Y, Shimada K
J Atheroscler Thromb. 2023; 31(3):273-287.
PMID: 37704429
PMC: 10918031.
DOI: 10.5551/jat.64251.
Significance of pharmacist intervention to oral antithrombotic therapy in the pharmaceutical outpatient clinic of cardiovascular internal medicine: a retrospective cohort study.
Kurimura T, Yamamoto K, Tanaka H, Toba T, Kimura T, Habu Y
J Pharm Health Care Sci. 2023; 9(1):28.
PMID: 37667376
PMC: 10478176.
DOI: 10.1186/s40780-023-00296-9.
Impact of heart failure severity and major bleeding events after percutaneous coronary intervention on subsequent major adverse cardiac events.
Ikebe S, Ishii M, Otsuka Y, Nakamura T, Tsujita K, Matoba T
Int J Cardiol Cardiovasc Risk Prev. 2023; 18:200193.
PMID: 37415925
PMC: 10320317.
DOI: 10.1016/j.ijcrp.2023.200193.
